Priority Date: 01.07.11 (EP 20110172324)

1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES

  • Application ID: EP12737238
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) De Clercq & Partners cvba is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 01.07.2011 - Priority Date (EP 20110172324)
  • 10.01.2013 - Publication A1 (WO2013004642)
  • 07.05.2014 - Publication A1 (EP2726470)
  • 29.04.2015 - Publication B1 (EP2726470)